Table 3 Comparison of ICON-JIA results and data in the general population
JIA patients | General population | ||||||
|---|---|---|---|---|---|---|---|
study | ICON-JIA | Laass et al. [16] | Taubner et al. [18] | Wolf et al. [19] | Mustalahti et al. [17] | Kabelitz et al. [15] | García-García et al. [14] |
year | 2015 | 2013 | 2017 | 2010 | 2003 | 2012 | |
country | Germany | Germany | Germany | Germany, Austria, United Kingdom | United Kingdom, Italy | Germany | Spain |
Age | 2–22 years (mean 6.8 years) | 1–17 years | 1–20 years | 5 month-18 years (mean 10.2 years) | 0–19 years | 1–19 years (median 11 years) | 1–16 years (mean 8.4 years) |
n (male/female) | 499 (166/333) | 12,741 (6546/6195) | 670 (351/319) | 345 (151/194) | 4620 (2271/2349) | 660 (293/367) | 1387 (710/677) |
anti-TG | 15 (3.01%) | 44 (6.6%) | 42 (3.0%) | ||||
anti-TPO | 20 (4.01%) | 149 (1,2%) | 16 (2.4%) | 22 (3.4%) | 29 (2.1%) | ||
anti-tTG IgA | 2 (0.4%) | 92 (0.7%) | 2 (0.6%) | 51 (1.1%) | |||
anti-tTG IgG | 2 (0.4%) | 7 (0.05%) | |||||